{"cik":2096997,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"Kailera Therapeutics, Inc.","units":{"USD":[{"end":"2025-10-31","val":10600000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26"},{"end":"2025-10-31","val":10600000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q3I"},{"end":"2025-12-31","val":10463000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26"},{"end":"2025-12-31","val":10463000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q4I"},{"end":"2026-03-31","val":10170000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26","frame":"CY2026Q1I"},{"end":"2026-06-30","val":9898000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2026Q2I"}]}}